These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15081103)

  • 41. Recent advances in prevention and treatment of hepatitis C virus infections.
    Wang QM; Heinz BA
    Prog Drug Res; 2000; 55():1-32. PubMed ID: 11127961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emerging drugs for chronic hepatitis C.
    Bhopale GM; Nanda RK
    Hepatol Res; 2005 Jul; 32(3):146-53. PubMed ID: 16023410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Advances in Antiviral Delivery Systems and Chitosan-Based Polymeric and Nanoparticulate Antivirals and Antiviral Carriers.
    Žigrayová D; Mikušová V; Mikuš P
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992356
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Altered thymic function during interferon therapy in HCV-infected patients.
    Beq S; Rozlan S; Pelletier S; Willems B; Bruneau J; Lelievre JD; Levy Y; Shoukry NH; Cheynier R
    PLoS One; 2012; 7(4):e34326. PubMed ID: 22529911
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Do statins reduce hepatitis C RNA titers during routine clinical use?
    Forde KA; Law C; O'Flynn R; Kaplan DE
    World J Gastroenterol; 2009 Oct; 15(40):5020-7. PubMed ID: 19859994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic issues in HIV/HCV-coinfected patients.
    Sulkowski MS; Benhamou Y
    J Viral Hepat; 2007 Jun; 14(6):371-86. PubMed ID: 17501757
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term treatment with the combination of amantadine and ribavirin in hepatitis C nonresponders. A case series.
    Riley TR; Taheri MR
    Dig Dis Sci; 2007 Dec; 52(12):3418-22. PubMed ID: 17401686
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluating replication-defective vesicular stomatitis virus as a vaccine vehicle.
    Majid AM; Ezelle H; Shah S; Barber GN
    J Virol; 2006 Jul; 80(14):6993-7008. PubMed ID: 16809305
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nonresponders to Previous Chronic Hepatitis C Treatment.
    Gross JB
    Curr Treat Options Gastroenterol; 2004 Dec; 7(6):469-475. PubMed ID: 15527713
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current therapy and new molecular approaches to antiviral treatment and prevention of hepatitis C.
    Hügle T; Cerny A
    Rev Med Virol; 2003; 13(6):361-71. PubMed ID: 14625884
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Past, present, and future hepatitis C treatments.
    Foster GR
    Semin Liver Dis; 2004; 24 Suppl 2():97-104. PubMed ID: 15346252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New therapies for the treatment of chronic hepatitis C.
    Idéo G; Bellobuono A
    Curr Pharm Des; 2002; 8(11):959-66. PubMed ID: 11945142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis C: therapeutic perspectives.
    Cornberg M; Wedemeyer H; Manns MP
    Forum (Genova); 2001; 11(2):154-62. PubMed ID: 11948360
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Future trends in managing hepatitis C.
    McHutchison JG; Dev AT
    Gastroenterol Clin North Am; 2004 Mar; 33(1 Suppl):S51-61. PubMed ID: 15081103
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.